A CME/CPE/MOC Activity
Click here to complete your registration.
If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.
DATES AND TIMES
Tuesday, March 16, 2021
4:00 - 5:00 PM ET (3:00 - 4:00 PM CT / 1:00 - 2:00 PM PT)
Wednesday, March 24, 2021
7:00 - 8:00 PM ET (6:00 - 7:00 PM CT / 4:00 - 5:00 PM PT)
Thursday, April 15, 2021
12:00 - 1:00 PM ET (11:00 AM - 12:00 PM CT / 9:00 - 10:00 AM PT)
Welcome and Introduction
New Approaches to Prostate Cancer Care
Managing Prostate Cancer During the COVID-19 Pandemic
Q&A Session and Activity Roundup
The treatment of advanced prostate cancer has changed significantly in recent years, from the introduction of chemotherapy and androgen inhibitors to the metastatic hormone-sensitive prostate cancer (HSPC) setting, to the recognition of non-metastatic castration-resistant prostate cancer (nmCRPC) as a disease state with multiple effective treatment options. However, the biggest change to how patients with prostate cancer are managed has come in the past year with the COVID-19 pandemic. Because patients with cancer are at increased risk of complications due to COVID-19 infection, their care must be prudently managed during this time. While delaying prostate cancer treatment is an option for some patients, telemedicine has emerged as a potential alternative to in-person care that reduces risk of Sars-CoV-2 transmission while maintaining standards and quality of care while patients wait for access to vaccines.
"Managing Advanced Prostate Cancer in the COVID-19 Era: What Do Oncologists Need to Know?" will provide oncologists with the most up-to-date evidence-based information and expert guidance on selecting and sequencing therapies in advanced prostate cancer and managing patient care during the COVID-19 pandemic.
Steven Ludlow, PharmD, BCOP, BCPS
Medical Oncology Clinical Pharmacy Specialist
H. Lee Moffitt Cancer Center and Research Institute
Alicia K. Morgans, MD, MPH
Associate Professor of Medicine
Northwestern University Feinberg School of Medicine
Scott T. Tagawa, MD, MS, FACP
Professor of Medicine & Urology
Medical Director, Genitourinary Oncology Research Program
Leader, GU Disease Management Team, Meyer Cancer Center
Weill Cornell Medical College
New York, NY
The intended audience for this educational initiative is oncologists and other clinicians involved in the management of patients with prostate cancer.
The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.
This program is designed to address ACPE competencies, including foundational knowledge, essentials for practice and care, and approaches to practice and care.
At the conclusion of this education, participants should be able to:
- Evaluate current and emerging treatments for patients with advanced prostate cancer based on clinical trial safety and efficacy data
- Develop patient-personalized treatment plans for advanced prostate cancer across all stages of disease
- Integrate consensus recommendations for the safe and effective management of prostate cancer during the COVID-19 pandemic
- Adopt recommended practices for appropriate integration of telemedicine into prostate cancer care
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit or the evaluation, please email firstname.lastname@example.org.
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
PHARMACIST ACCREDITATION STATEMENT
The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PHARMACIST CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-21-002-L01-P).
This is an application-based activity.
For information about this continuing pharmacy education (CPE) activity, please email: email@example.com.
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.
Disclosures will be made known to the participants prior to the start of the activity.
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
To ensure your computer is compatible for the live event, please perform a system check by clicking on the link http://livewebcast.net/test or by typing it into your internet browser. Please perform the system check on the same computer you will use for the live event. If your computer is compatible, you will receive a confirmation message on your screen and hear audio. Otherwise, please contact the Help Desk to resolve any issues.
1.4 GHz Intel Pentium 4 or faster processor (or equivalent) Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit) 512 MB of RAM (1 GB recommended) Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome For HTML Client - Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above) 1.83 GHz Intel Core Duo or faster processor 512 MB RAM (1 GB recommended) Mac OS X 10.12, 10.13 and 10.14 Mozilla Firefox, Apple Safari, Google Chrome For HTML Client - Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above) The Adobe Connect app for iOS and Android requires Adobe Connect Server version 8.2 or later Some features may not be enabled in all Adobe Connect meetings if one is using an Adobe Connect Server older than version 9.4.2 (required for Custom pods) Google Android 4.4 or later Apple iOS: iOS 8.1.2 or later
DSL/cable (wired connection recommended)
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/CE CREDIT AND MOC POINTS
There is no fee for this activity. To receive credit, participants must register, view the live CME/CE activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
This educational activity is supported by medical educational grants from Astellas/Pfizer, Inc. and Exelixis, Inc.